{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:56:33Z","timestamp":1774025793496,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"esearch Council of the University of Hong Kon","award":["104004460"],"award-info":[{"award-number":["104004460"]}]},{"name":"esearch Council of the University of Hong Kon","award":["104003422"],"award-info":[{"award-number":["104003422"]}]},{"name":"esearch Council of the University of Hong Kon","award":["104004092"],"award-info":[{"award-number":["104004092"]}]},{"name":"Wong\u2019s donation","award":["200006276"],"award-info":[{"award-number":["200006276"]}]},{"name":"a donation from the Gaia Family Trust of New Zealand","award":["200007008"],"award-info":[{"award-number":["200007008"]}]},{"name":"a contract research project","award":["200007482"],"award-info":[{"award-number":["200007482"]}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["740608"],"award-info":[{"award-number":["740608"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["766211"],"award-info":[{"award-number":["766211"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17152116"],"award-info":[{"award-number":["17152116"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["15162961"],"award-info":[{"award-number":["15162961"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12964-019-0396-5","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T13:03:26Z","timestamp":1563800606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["OMICs approaches-assisted identification of macrophages-derived MIP-1\u03b3 as the therapeutic target of botanical products TNTL in diabetic retinopathy"],"prefix":"10.1186","volume":"17","author":[{"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hor-Yue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"396_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","volume":"96","author":"D Pascolini","year":"2012","unstructured":"Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614\u20138.","journal-title":"Br J Ophthalmol"},{"key":"396_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.survophthal.2012.01.004","volume":"57","author":"S Sivaprasad","year":"2012","unstructured":"Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol. 2012;57:347\u201370.","journal-title":"Surv Ophthalmol"},{"key":"396_CR3","first-page":"486","volume":"22","author":"RA Gangwani","year":"2016","unstructured":"Gangwani RA, Lian JX, McGhee SM, Wong D, Li KK. Diabetic retinopathy screening: global and local perspective. Hong Kong Med J. 2016;22:486\u201395.","journal-title":"Hong Kong Med J"},{"key":"396_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1874364101307010004","volume":"7","author":"N Gupta","year":"2013","unstructured":"Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, Kuppermann B, Kenney M. Diabetic retinopathy and VEGF. Open Ophthalmol J. 2013;7:4\u201310.","journal-title":"Open Ophthalmol J"},{"key":"396_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","volume":"27","author":"JS Penn","year":"2008","unstructured":"Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27:331\u201371.","journal-title":"Prog Retin Eye Res"},{"key":"396_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1001288","volume":"363","author":"EY Chew","year":"2010","unstructured":"Group AS, Group AES, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233\u201344.","journal-title":"N Engl J Med"},{"key":"396_CR7","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/jcb.25575","volume":"117","author":"M Capitao","year":"2016","unstructured":"Capitao M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem. 2016;117:2443\u201353.","journal-title":"J Cell Biochem"},{"key":"396_CR8","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1111\/j.1755-3768.2010.02030.x","volume":"88","author":"MG Petrovic","year":"2010","unstructured":"Petrovic MG, Korosec P, Kosnik M, Hawlina M. Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy. Acta Ophthalmol. 2010;88:e311\u20136.","journal-title":"Acta Ophthalmol"},{"key":"396_CR9","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1167\/iovs.13-12212","volume":"54","author":"MS Roy","year":"2013","unstructured":"Roy MS, Janal MN, Crosby J, Donnelly R. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci. 2013;54:5471\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"396_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj\/eye\/6700095","volume":"16","author":"S Doganay","year":"2002","unstructured":"Doganay S, Evereklioglu C, Er H, Turkoz Y, Sevinc A, Mehmet N, Savli H. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye (Lond). 2002;16:163\u201370.","journal-title":"Eye (Lond)"},{"key":"396_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.visres.2017.04.013","volume":"139","author":"H Xu","year":"2017","unstructured":"Xu H, Chen M. Diabetic retinopathy and dysregulated innate immunity. Vis Res. 2017;139:39\u201346.","journal-title":"Vis Res"},{"key":"396_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","volume":"2","author":"R Lee","year":"2015","unstructured":"Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17.","journal-title":"Eye Vis (Lond)"},{"key":"396_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.lfs.2016.08.001","volume":"162","author":"FS Sorrentino","year":"2016","unstructured":"Sorrentino FS, Allkabes M, Salsini G, Bonifazzi C, Perri P. The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life Sci. 2016;162:54\u20139.","journal-title":"Life Sci"},{"key":"396_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jep.2015.04.031","volume":"169","author":"L Wang","year":"2015","unstructured":"Wang L, Wang N, Tan HY, Zhang Y, Feng Y. Protective effect of a Chinese medicine formula he-Ying-Qing-re formula on diabetic retinopathy. J Ethnopharmacol. 2015;169:295\u2013304.","journal-title":"J Ethnopharmacol"},{"key":"396_CR15","doi-asserted-by":"publisher","first-page":"E209","DOI":"10.1073\/pnas.1616811114","volume":"114","author":"Y Li","year":"2017","unstructured":"Li Y, Andereggen L, Yuki K, Omura K, Yin Y, Gilbert HY, Erdogan B, Asdourian MS, Shrock C, de Lima S, et al. Mobile zinc increases rapidly in the retina after optic nerve injury and regulates ganglion cell survival and optic nerve regeneration. Proc Natl Acad Sci U S A. 2017;114:E209\u201318.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"396_CR16","first-page":"1122","volume":"22","author":"R Liu","year":"2016","unstructured":"Liu R, Wang Y, Pu M, Gao J. Effect of alpha lipoic acid on retinal ganglion cell survival in an optic nerve crush model. Mol Vis. 2016;22:1122\u201336.","journal-title":"Mol Vis"},{"key":"396_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nprot.2015.052","volume":"10","author":"J Xia","year":"2015","unstructured":"Xia J, Gill EE, Hancock RE. NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc. 2015;10:823\u201344.","journal-title":"Nat Protoc"},{"key":"396_CR18","doi-asserted-by":"publisher","first-page":"W167","DOI":"10.1093\/nar\/gku443","volume":"42","author":"J Xia","year":"2014","unstructured":"Xia J, Benner MJ, Hancock RE. NetworkAnalyst--integrative approaches for protein-protein interaction network analysis and visual exploration. Nucleic Acids Res. 2014;42:W167\u201374.","journal-title":"Nucleic Acids Res"},{"key":"396_CR19","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/bioinformatics\/btt562","volume":"29","author":"J Xia","year":"2013","unstructured":"Xia J, Lyle NH, Mayer ML, Pena OM, Hancock RE. INVEX--a web-based tool for integrative visualization of expression data. Bioinformatics. 2013;29:3232\u20134.","journal-title":"Bioinformatics"},{"key":"396_CR20","doi-asserted-by":"publisher","first-page":"W63","DOI":"10.1093\/nar\/gkt338","volume":"41","author":"J Xia","year":"2013","unstructured":"Xia J, Fjell CD, Mayer ML, Pena OM, Wishart DS, Hancock RE. INMEX--a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res. 2013;41:W63\u201370.","journal-title":"Nucleic Acids Res"},{"key":"396_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.271","volume":"6","author":"HY Tan","year":"2015","unstructured":"Tan HY, Wang N, Man K, Tsao SW, Che CM, Feng Y. Autophagy-induced RelB\/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin. Cell Death Dis. 2015;6:e1942.","journal-title":"Cell Death Dis"},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/2211068214561025","volume":"20","author":"B Srinivasan","year":"2015","unstructured":"Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20:107\u201326.","journal-title":"J Lab Autom"},{"key":"396_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/mmr.2017.6679","volume":"16","author":"L Cheng","year":"2017","unstructured":"Cheng L, Song J, Li G, Liu Y, Wang Y, Meng X, Sun G, Sun X. Effects of the Tangningtongluo formula as an alternative strategy for diabetics via upregulation of insulin receptor substrate-1. Mol Med Rep. 2017;16:703\u20139.","journal-title":"Mol Med Rep"},{"key":"396_CR24","doi-asserted-by":"publisher","first-page":"745419","DOI":"10.1155\/2014\/745419","volume":"2014","author":"L Cheng","year":"2014","unstructured":"Cheng L, Meng XB, Lu S, Wang TT, Liu Y, Sun GB, Sun XB. Evaluation of hypoglycemic efficacy of tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models. J Diabetes Res. 2014;2014:745419.","journal-title":"J Diabetes Res"},{"key":"396_CR25","doi-asserted-by":"publisher","first-page":"i6505","DOI":"10.1136\/bmj.i6505","volume":"356","author":"WM Valencia","year":"2017","unstructured":"Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. BMJ. 2017;356:i6505.","journal-title":"BMJ"},{"key":"396_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jep.2017.12.018","volume":"214","author":"C Zhang","year":"2018","unstructured":"Zhang C, Xu Y, Tan HY, Li S, Wang N, Zhang Y, Feng Y. Neuroprotective effect of he-Ying-Qing-re formula on retinal ganglion cell in diabetic retinopathy. J Ethnopharmacol. 2018;214:179\u201389.","journal-title":"J Ethnopharmacol"},{"key":"396_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.exer.2011.08.011","volume":"93","author":"C Sippl","year":"2011","unstructured":"Sippl C, Bosserhoff AK, Fischer D, Tamm ER. Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp Eye Res. 2011;93:669\u201380.","journal-title":"Exp Eye Res"},{"key":"396_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuroscience.2015.08.060","volume":"307","author":"HE Vuong","year":"2015","unstructured":"Vuong HE, Perez de Sevilla Muller L, Hardi CN, McMahon DG, Brecha NC. Heterogeneous transgene expression in the retinas of the TH-RFP, TH-Cre, TH-BAC-Cre and DAT-Cre mouse lines. Neuroscience. 2015;307:319\u201337.","journal-title":"Neuroscience"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez AR, de Sevilla Muller LP, Brecha NC. The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J Comp Neurol. 2014;522:1411\u201343.","journal-title":"J Comp Neurol"},{"key":"396_CR30","doi-asserted-by":"publisher","first-page":"e0160309","DOI":"10.1371\/journal.pone.0160309","volume":"11","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang W, Liu J, Huang X, Liu R, Xia H, Brecha NC, Pu M, Gao J. Protective effect of ALA in crushed optic nerve cat retinal ganglion cells using a new marker RBPMS. PLoS One. 2016;11:e0160309.","journal-title":"PLoS One"},{"key":"396_CR31","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1167\/iovs.16-21168","volume":"58","author":"EA Obara","year":"2017","unstructured":"Obara EA, Hannibal J, Heegaard S, Fahrenkrug J. Loss of Melanopsin-expressing retinal ganglion cells in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:2187\u201392.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"396_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajpath.2016.08.022","volume":"187","author":"S Roy","year":"2017","unstructured":"Roy S, Kern TS, Song B, Stuebe C. Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy. Am J Pathol. 2017;187:9\u201319.","journal-title":"Am J Pathol"},{"key":"396_CR33","first-page":"2250","volume":"43","author":"MJ Robertson","year":"2002","unstructured":"Robertson MJ, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis. Invest Ophthalmol Vis Sci. 2002;43:2250\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"396_CR34","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.4049\/jimmunol.155.11.5352","volume":"155","author":"T Hara","year":"1995","unstructured":"Hara T, Bacon KB, Cho LC, Yoshimura A, Morikawa Y, Copeland NG, Gilbert DJ, Jenkins NA, Schall TJ, Miyajima A. Molecular cloning and functional characterization of a novel member of the C-C chemokine family. J Immunol. 1995;155:5352\u20138.","journal-title":"J Immunol"},{"key":"396_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jcb.10319","volume":"87","author":"JM Lean","year":"2002","unstructured":"Lean JM, Murphy C, Fuller K, Chambers TJ. CCL9\/MIP-1gamma and its receptor CCR1 are the major chemokine ligand\/receptor species expressed by osteoclasts. J Cell Biochem. 2002;87:386\u201393.","journal-title":"J Cell Biochem"},{"key":"396_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjp.0706912","volume":"149","author":"M Amat","year":"2006","unstructured":"Amat M, Benjamim CF, Williams LM, Prats N, Terricabras E, Beleta J, Kunkel SL, Godessart N. Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo. Br J Pharmacol. 2006;149:666\u201375.","journal-title":"Br J Pharmacol"},{"key":"396_CR37","first-page":"589","volume":"22","author":"N Wat","year":"2016","unstructured":"Wat N, Wong RL, Wong IY. Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J. 2016;22:589\u201399.","journal-title":"Hong Kong Med J"},{"key":"396_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","volume":"304","author":"X Zhang","year":"2010","unstructured":"Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649\u201356.","journal-title":"JAMA"},{"key":"396_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527\u201332.","journal-title":"Arch Ophthalmol"},{"key":"396_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1746-1596-9-130","volume":"9","author":"C Zhao","year":"2014","unstructured":"Zhao C, Wang W, Xu D, Li H, Li M, Wang F. Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies. Diagn Pathol. 2014;9:130.","journal-title":"Diagn Pathol"},{"key":"396_CR41","doi-asserted-by":"publisher","first-page":"e000027","DOI":"10.1136\/bmjdrc-2014-000027","volume":"2","author":"JZ Kuo","year":"2014","unstructured":"Kuo JZ, Guo X, Klein R, Klein BE, Weinreb RN, Genter P, Hsiao FC, Goodarzi MO, Rotter JI, Chen YD, Ipp E. Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes. BMJ Open Diabetes Res Care. 2014;2:e000027.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"396_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000459691","volume":"60","author":"R Lattanzio","year":"2017","unstructured":"Lattanzio R, Cicinelli MV, Bandello F. Intravitreal steroids in diabetic macular edema. Dev Ophthalmol. 2017;60:78\u201390.","journal-title":"Dev Ophthalmol"},{"key":"396_CR43","first-page":"CD011599","volume":"4","author":"H Mehta","year":"2018","unstructured":"Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database Syst Rev. 2018;4:CD011599.","journal-title":"Cochrane Database Syst Rev"},{"key":"396_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/0974-9233.92116","volume":"19","author":"S Rangasamy","year":"2012","unstructured":"Rangasamy S, McGuire PG, Das A. Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol. 2012;19:52\u20139.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"396_CR45","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067\u201372.","journal-title":"Circulation"},{"issue":"Suppl 2","key":"396_CR46","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.2337\/dcS15-3015","volume":"39","author":"RM Pollack","year":"2016","unstructured":"Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care. 2016;39(Suppl 2):S244\u201352.","journal-title":"Diabetes Care"},{"key":"396_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/archopht.124.5.643","volume":"124","author":"F Bandello","year":"2006","unstructured":"Bandello F, Polito A, Pognuz DR, Monaco P, Dimastrogiovanni A, Paissios J. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol. 2006;124:643\u201350.","journal-title":"Arch Ophthalmol"},{"key":"396_CR48","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jamaophthalmol.2013.4154","volume":"131","author":"SB Bressler","year":"2013","unstructured":"Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG. Diabetic retinopathy clinical research N: exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. JAMA Ophthalmol. 2013;131:1033\u201340.","journal-title":"JAMA Ophthalmol"},{"key":"396_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10792-007-9042-0","volume":"26","author":"B Kaderli","year":"2005","unstructured":"Kaderli B, Avci R, Gelisken O, Yucel AA. Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO. Int Ophthalmol. 2005;26:207\u201314.","journal-title":"Int Ophthalmol"},{"key":"396_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/IAE.0b013e3181b4f125","volume":"30","author":"A Mirshahi","year":"2010","unstructured":"Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Retina. 2010;30:254\u20139.","journal-title":"Retina"},{"key":"396_CR51","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/archophthalmol.2009.308","volume":"127","author":"NM Bressler","year":"2009","unstructured":"Bressler NM, Edwards AR, Beck RW, Flaxel CJ, Glassman AR, Ip MS, Kollman C, Kuppermann BD, Stone TW. Diabetic retinopathy clinical research N: exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal\/grid photocoagulation. Arch Ophthalmol. 2009;127:1566\u201371.","journal-title":"Arch Ophthalmol"},{"key":"396_CR52","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/bjophthalmol-2017-311377","volume":"102","author":"Y Takamura","year":"2018","unstructured":"Takamura Y, Shimura M, Katome T, Someya H, Sugimoto M, Hirano T, Sakamoto T, Gozawa M, Matsumura T, Inatani M. Writing committee of Japan-clinical retina research T: effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy. Br J Ophthalmol. 2018;102:1351\u20137.","journal-title":"Br J Ophthalmol"},{"key":"396_CR53","first-page":"213130","volume":"2013","author":"S Kastelan","year":"2013","unstructured":"Kastelan S, Tomic M, Gverovic Antunica A, Salopek Rabatic J, Ljubic S. Inflammation and pharmacological treatment in diabetic retinopathy. Mediat Inflamm. 2013;2013:213130.","journal-title":"Mediat Inflamm"},{"key":"396_CR54","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0161-6420(13)38010-5","volume":"98","author":"Effects of aspirin treatment on diabetic retinopathy","year":"1991","unstructured":"Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:757\u201365.","journal-title":"Ophthalmology"},{"key":"396_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","volume":"55","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55:108\u201333.","journal-title":"Surv Ophthalmol"},{"key":"396_CR56","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.biochi.2010.05.004","volume":"92","author":"S Sheikpranbabu","year":"2010","unstructured":"Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability. Biochimie. 2010;92:1040\u201351.","journal-title":"Biochimie"},{"key":"396_CR57","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.4103\/1673-5374.194758","volume":"11","author":"PS Yan","year":"2016","unstructured":"Yan PS, Tang S, Zhang HF, Guo YY, Zeng ZW, Wen Q. Nerve growth factor protects against palmitic acid-induced injury in retinal ganglion cells. Neural Regen Res. 2016;11:1851\u20136.","journal-title":"Neural Regen Res"},{"key":"396_CR58","first-page":"586","volume":"16","author":"CM Chan","year":"2010","unstructured":"Chan CM, Huang JH, Chiang HS, Wu WB, Lin HH, Hong JY, Hung CF. Effects of (\u2212)-epigallocatechin gallate on RPE cell migration and adhesion. Mol Vis. 2010;16:586\u201395.","journal-title":"Mol Vis"},{"key":"396_CR59","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cellsig.2017.09.019","volume":"40","author":"YC Chang","year":"2017","unstructured":"Chang YC, Lin CW, Hsieh MC, Wu HJ, Wu WS, Wu WC, Kao YH. High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells. Cell Signal. 2017;40:248\u201357.","journal-title":"Cell Signal"},{"key":"396_CR60","first-page":"1024","volume":"19","author":"Z Ran","year":"2019","unstructured":"Ran Z, Zhang Y, Wen X, Ma J. Curcumin inhibits high glucoseinduced inflammatory injury in human retinal pigment epithelial cells through the ROSPI3K\/AKT\/mTOR signaling pathway. Mol Med Rep. 2019;19:1024\u201331.","journal-title":"Mol Med Rep"},{"key":"396_CR61","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.4049\/jimmunol.1502494","volume":"197","author":"S Niu","year":"2016","unstructured":"Niu S, Bian Z, Tremblay A, Luo Y, Kidder K, Mansour A, Zen K, Liu Y. Broad infiltration of macrophages leads to a Proinflammatory state in Streptozotocin-induced hyperglycemic mice. J Immunol. 2016;197:3293\u2013301.","journal-title":"J Immunol"},{"key":"396_CR62","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4049\/jimmunol.173.3.2084","volume":"173","author":"Y Okamatsu","year":"2004","unstructured":"Okamatsu Y, Kim D, Battaglino R, Sasaki H, Spate U, Stashenko P. MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol. 2004;173:2084\u201390.","journal-title":"J Immunol"},{"key":"396_CR63","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1182\/blood-2005-08-3365","volume":"107","author":"M Yang","year":"2006","unstructured":"Yang M, Mailhot G, MacKay CA, Mason-Savas A, Aubin J, Odgren PR. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro. Blood. 2006;107:2262\u201370.","journal-title":"Blood"},{"key":"396_CR64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cyto.2005.01.018","volume":"30","author":"J Hwang","year":"2005","unstructured":"Hwang J, Son KN, Kim CW, Ko J, Na DS, Kwon BS, Gho YS, Kim J. Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine. 2005;30:254\u201363.","journal-title":"Cytokine"},{"key":"396_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2003-05-1387","volume":"103","author":"M Strasly","year":"2004","unstructured":"Strasly M, Doronzo G, Cappello P, Valdembri D, Arese M, Mitola S, Moore P, Alessandri G, Giovarelli M, Bussolino F. CCL16 activates an angiogenic program in vascular endothelial cells. Blood. 2004;103:40\u20139.","journal-title":"Blood"},{"key":"396_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.febslet.2004.06.023","volume":"570","author":"J Hwang","year":"2004","unstructured":"Hwang J, Kim CW, Son KN, Han KY, Lee KH, Kleinman HK, Ko J, Na DS, Kwon BS, Gho YS, Kim J. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett. 2004;570:47\u201351.","journal-title":"FEBS Lett"},{"key":"396_CR67","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bbrc.2005.12.037","volume":"340","author":"KN Son","year":"2006","unstructured":"Son KN, Hwang J, Kwon BS, Kim J. Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells. Biochem Biophys Res Commun. 2006;340:498\u2013504.","journal-title":"Biochem Biophys Res Commun"},{"key":"396_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4161\/cam.25138","volume":"7","author":"M Swamydas","year":"2013","unstructured":"Swamydas M, Ricci K, Rego SL, Dreau D. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases. Cell Adhes Migr. 2013;7:315\u201324.","journal-title":"Cell Adhes Migr"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-019-0396-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-019-0396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T12:44:59Z","timestamp":1695041099000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-019-0396-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s12964-019-0396-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Protocols of animal study were reviewed and approved by the Committee on the Use of Live Animals in Teaching and Research (CULATR) of the University of Hong Kong.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Feng Yibin received grant support from Bailing Pharmaceutical Group Co. (Guizhou, China), who provided the standard extract of TNTL for the whole study. Other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}